Anti-Mucin1 (MUC1) CAR T Cells

MUC1-targeted CAR T cells · PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-Mucin1 (MUC1) CAR T Cells, covering 2016-12-05 to 2016-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor [Phase 1, Phase 2]

See pricing